Susquehanna International Group, LLP Oric Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $568 Billion
  • Q1 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$4.95 - $8.4 $281,160 - $477,120
56,800 Added 433.59%
69,900 $542,000
Q1 2023

May 16, 2023
SELL
$4.26 - $6.75 $60,492 - $95,850
-14,200 Reduced 52.01%
13,100 $74,000
Q4 2022

Feb 14, 2023
SELL
$2.41 - $5.89 $179,304 - $438,216
-74,400 Reduced 73.16%
27,300 $160,000
Q3 2022

Nov 14, 2022
SELL
$3.28 - $5.24 $12,464 - $19,912
-3,800 Reduced 3.6%
101,700 $325,000

Others Institutions Holding ORIC

# of Institutions
113
Shares Held
59.3M
Call Options Held
302K
Put Options Held
7.7K
View Full List

About Oric Pharmaceuticals, Inc.

ORIC Quotes by TradingView
  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $304M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email